Acasti Pharma - 53 Year Dividend History | GRCE
Historical dividend payout and yield for Acasti Pharma (GRCE) since 1971. The current TTM dividend payout for Acasti Pharma (GRCE) as of October 29, 2024 is $0.00. The current dividend yield for Acasti Pharma as of October 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
